Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 347

The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.

Breast cancer precursors revisited: molecular features and progression pathways

Lopez‐Garcia, Maria A, Geyer, Felipe C, Lacroix‐Triki, Magali, Marchió, Caterina, Reis‐Filho, Jorge S·2010·Histopathology

Abstract

Lopez‐Garcia M A, Geyer F C, Lacroix‐Triki M, Marchió C & Reis‐Filho J S (2010) Histopathology 57, 171–192 Breast cancer precursors revisited: molecular features and progression pathways Increasingly more coherent data on the molecular characteristics of benign breast lesions and breast cancer precursors have led to the delineation of new multistep pathways of breast cancer progression through genotypic–phenotypic correlations. It has become apparent that oestrogen receptor (ER)‐positive and ‐negative breast lesions are fundamentally distinct diseases. Within the ER‐positive group, histological grade is strongly associated with the number and complexity of genetic abnormalities in breast cancer cells. Genomic analyses of high‐grade ER‐positive breast cancers have revealed that a substantial proportion of these tumours harbour the characteristic genetic aberrations found in low‐grade ER‐positive disease, suggesting that at least a subgroup of high‐grade ER‐positive breast cancers may originate from low‐grade lesions. The ER‐negative group is more complex and heterogeneous, comprising distinct molecular entities, including basal‐like, HER2 and molecular apocrine lesions. Importantly, the type and pattern of genetic aberrations found in ER‐negative cancers differ from those of ER‐positive disease. Here, we review the available molecular data on breast cancer risk indicator and precursor lesions, the putative mechanisms of progression from in situ to invasive disease, and propose a revised model of breast cancer evolution based on the molecular characteristics of distinct subtypes of in situ and invasive breast cancers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2559.2010.03568.x

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 109 references

Cited by

See all 347

Metadata

Authors
Lopez‐Garcia, M. A., Geyer, F. C., Lacroix‐Triki, M., Marchió, C., & Reis‐Filho, J. S.
Venue
Histopathology
Publisher
Wiley
Published
2010-08
Volume
57
Issue
2
Pages
171-192
ISSN
  • 0309-0167 (ISSN-L)
  • 1365-2559
OpenAlex
W2125401785
Cited by
347
References
109
FWCI
14.81
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Breast cancer precursors revisited: molecular features and progression pathways. https://app.cochat.ai/papers/10.1111/j.1365-2559.2010.03568.x
The paper
Lopez‐Garcia, M. A., Geyer, F. C., Lacroix‐Triki, M., Marchió, C., & Reis‐Filho, J. S. (2010). Breast cancer precursors revisited: molecular features and progression pathways. Histopathology. https://doi.org/10.1111/j.1365-2559.2010.03568.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.